It blocks the TNF-alpha protein which is primarily responsible for inflammation.
Simpler, it blocks inflammation from happening
Anonymous 0
Comments
Adalimumab (brand name humira) is a monoclonal antibody directed at a signaling molecule named TNF. TNF provides a broadly inflammation-inducing signal when it gets to bind its receptors, so blocking it from doing so combats inflammation.
Latest Answers